4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001737287-26-000007
CHIEF FINANCIAL OFFICER sold 24,001 shares at $1.76 ($42,242)
From the SEC's structured data for this filing
Trades in this filing
Parker Geoffrey M. · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sale : show line 1 in the form | −24,001 | $1.76 | $42,242 | 1,252,795 | D |
| Open-market sales · 24,001 sh · avg $1.76 · $42,242 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Grant or award : show line 2 in the form Stock Option (Right to buy) | +539,072 | 539,072 | D |
| 2026-02-02 | Grant or award : show line 3 in the form Restricted Stock Unit | +152,480 | 152,480 | D |
Loading xslF345X05/wk-form4_1770243376.xml…